Anti–N-Methyl-D-Aspartate Receptor Encephalitis and Rasmussen-like Syndrome: An Association?

Bien, 2005, Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement, Brain, 128, 454, 10.1093/brain/awh415 Olson, 2013, Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis, Epilepsia, 54, 1753, 10.1111/epi.12334 Greiner, 2011, Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome, Seizure, 20, 266, 10.1016/j.seizure.2010.11.013 Takahashi, 2005, Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua, Epilepsia, 46 Suppl 5, 152, 10.1111/j.1528-1167.2005.01024.x Nibber, 2016, Antibodies to AMPA receptors in Rasmussen's encephalitis, Eur J Paediatr Neurol, 20, 222, 10.1016/j.ejpn.2015.12.011 Fukuyama, 2015, Semi-quantitative analyses of antibodies to N-methyl-D-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome, Epilepsy Res, 113, 34, 10.1016/j.eplepsyres.2015.03.004